Vascular risk factors are associated with faster decline of Alzheimer disease: A longitudinal SPECT study

Journal of Neurology

Volumn 258, Issue 7, 2011, Pages 1295-1303

  Kume, Kazumasa ^a   Hanyu, Haruo ^a   Sato, Tomohiko ^a   Hirao, Kentaro ^a   Shimizu, Soichiro ^a   Kanetaka, Hidekazu ^a   Sakurai, Hiofumi ^a   Iwamoto, Toshihiko ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Alzheimer disease; Cerebral blood flow; Diabetes; Hypercholesterolemia; Hypertension; Progression

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; CHOLINESTERASE INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IOFETAMINE I 123; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; IMAGE ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MENTAL DETERIORATION; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; OUTPATIENT; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; BRAIN; BRAIN MAPPING; CARDIOVASCULAR DISEASES; CEREBROVASCULAR CIRCULATION; DISEASE PROGRESSION; FEMALE; FUNCTIONAL LATERALITY; HUMANS; LONGITUDINAL STUDIES; MALE; RISK FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79961030709     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-5927-y     Document Type: Article

References (39)

1. MS Beeri J Schmeidler JM Silverman, et al. 2008 Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology Neurology 71 750 757 18765651 10.1212/01.wnl.0000324925.95210.6d 1:CAS:528:DC%2BD1cXhtVejtr7K
2. I Boksay B Reisberg C Torossian, et al. 2005 Alzheimer's disease and medical disease conditions: a prospective cohort study J Am Geriatr Soc 53 2235 2236 16398919 10.1111/j.1532-5415.2005.00512-4.x (Pubitemid 43001215)
3. NJ Dougall S Bruggink KP Ebmeier 2004 Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia Am J Geriatr Psychiatry 12 554 570 15545324 (Pubitemid 41031058)
4. RM Evans S Hui A Perkins, et al. 2004 Cholesterol and APOE genotype interact to influence Alzheimer disease progression Neurology 62 1869 1871 15159498 1:CAS:528:DC%2BD2cXjs1yltLk%3D (Pubitemid 38661755)
5. MF Folstein SE Folstein PR McHugh 1975 Mini-mental state. A practical method for grading the cognitive state of patients for the clinician J Psychiatr Res 12 189 198 1202204 10.1016/0022-3956(75)90026-6 1:STN:280: DyaE28%2FntFKjtw%3D%3D
6. F Forette ML Seux JA Staessen, et al. 2002 Systolic hypertension in Europe investigators. The prevention of dementia with antihypertensive treatment. New evidence from the systolic hypertension in Europe (Syst-Eur) study Arch Intern Med 162 2046 2052 12374512 10.1001/archinte.162.18.2046 (Pubitemid 35168212)
7. JH Growdon JJ Locascio S Corkin, et al. 1996 Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease Neurology 47 444 448 8757018 1:STN:280:DyaK28zjs1SjsA%3D%3D (Pubitemid 26324041)
8. L Han M Cole F Bellevance, et al. 2000 Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: a meta-analysis Int Psychogeriatr 12 231 247 10937543 10.1017/S1041610200006359 1:STN:280:DC%2BD3M%2FlsFWkuw%3D%3D (Pubitemid 30490970)
9. JV Haxby K Raffaele J Gillette, et al. 1992 Individual trajectories of cognitive decline in patients with dementia of the Alzheimer type J Clin Exp Neuropsychol 14 575 592 1400920 10.1080/01688639208402846 1:STN:280: DyaK3s%2Fhs1KksQ%3D%3D
10. EP Helzner JA Luchsinger N Scarmeas, et al. 2009 Contribution of vascular risk factors to the progression in Alzheimer disease Arch Neurol 66 343 348 19273753 10.1001/archneur.66.3.343
11. CP Highes L Berg WL Danzieger, et al. 1982 A new clinical scale for the staging of dementia Br J Psychiatry 140 566 572 10.1192/bjp.140.6.566 (Pubitemid 12124384)
12. K Ishi F Willoch S Minoshima, et al. 2001 Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains J Nucl Med 42 548 557 (Pubitemid 32298272)
13. M Kivipelto EL Helkala MP Laakso, et al. 2002 Apolipoprotein E epsilon 4 allele, elevated midlife total cholesterol level, and high midlife systolic blood pressure are independent risk factors for late-life Alzheimer disease Ann Intern Med 137 149 155 12160362 1:CAS:528:DC%2BD38XmsFWrtbk%3D (Pubitemid 34827510)
14. T Kleiman K Zdanys B Black, et al. 2006 Apolipoprotein E epsilon 4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis Dement Geriatr Cogn Disord 22 73 82 16699282 10.1159/000093316
15. LJ Launer GW Ross H Petrovitch, et al. 2000 Midlife blood pressure and dementia: the Honolulu-Asia aging study Neurobiol Aging 21 49 55 10794848 10.1016/S0197-4580(00)00096-8 1:STN:280:DC%2BD3c3ls12mtg%3D%3D (Pubitemid 30224785)
16. G Li EB Larson JA Sonnen, et al. 2007 Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease Neurology 69 878 885 17724290 10.1212/01.wnl.0000277657.95487.1c 1:CAS:528:DC%2BD2sXptl2js78%3D (Pubitemid 47329587)
17. G McKhann D Drachman M Folstein, et al. 1984 Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 939 944 6610841 1:STN:280:DyaL2c3ks1altQ%3D%3D (Pubitemid 14076461)
18. MM Mielke PB Rosenberg J Tschanz, et al. 2007 Vascular factors predict rate of progression in Alzheimer disease Neurology 69 1850 1858 17984453 10.1212/01.wnl.0000279520.59792.fe 1:STN:280:DC%2BD2snlvF2jtg%3D%3D (Pubitemid 350071146)
19. S Minoshima RA Koeppe KA Frey, et al. 1994 Anatomic standardization: linear scaling and nonlinear warping of functional brain images J Nucl Med 35 1528 1537 8071705 1:STN:280:DyaK2czltFekug%3D%3D (Pubitemid 24280464)
20. S Minoshima KA Frey RA Koeppe, et al. 1995 A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET J Nucl Med 36 1238 1248 7790950 1:STN:280: DyaK2MzhtFSgtQ%3D%3D
21. S Mizumura S Kumita K Cho, et al. 2003 Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation Ann Nucl Med 17 289 295 12932111 10.1007/BF02988523 (Pubitemid 37012040)
22. GM Murphy Jr J Taylor HC Kraemer, et al. 1997 No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease Am J Psychiatry 154 603 608 9137113 (Pubitemid 27197591)
23. M Musicco K Palmer G Salamone, et al. 2009 Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors J Neurol 256 1288 1295 19353221 10.1007/s00415-009- 5116-4
24. IL Notkola R Sulkava J Pekkanen, et al. 1998 Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease Neuroepidemiology 17 14 20 9549720 10.1159/000026149 1:STN:280:DyaK1c3htVyruw%3D%3D (Pubitemid 28153361)
25. T Ohrui N Tomita T Sato-Nakagawa, et al. 2004 Effects of brain-penetrating ACE inhibitors on Alzheimer disease progression Neurology 63 1324 1325 15477567 1:STN:280:DC%2BD2crgvVWmug%3D%3D (Pubitemid 39350046)
26. A Ott RP Stolk F van Harskamp, et al. 1999 Diabetes mellitus and the risk of dementia: the rotterdam study Neurology 53 1937 1942 10599761 1:STN:280:DC%2BD3c%2Fms1Ontg%3D%3D
27. C Regan C Katona Z Walker, et al. 2006 Relationship of vascular risk to the progression of Alzheimer disease Neurology 67 1357 1362 17060560 10.1212/01.wnl.0000240129.46080.53 1:STN:280:DC%2BD28nislWlsQ%3D%3D (Pubitemid 44632057)
28. B Reisberg SH Ferris R Anand, et al. 1984 Functional staging of dementia of the Alzheimer's type Ann NY Scad Sci 485 481 483 10.1111/j.1749-6632.1984. tb13859.x (Pubitemid 15139466)
29. ME Risner AM Saunders JF Altman, et al. 2006 Rosiglitazone in Alzheimer's Disease Study Group. Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer's disease Pharmacogenom J 6 246 254 1:CAS:528:DC%2BD28Xnt1agu7k%3D (Pubitemid 44137951)
30. F Roselli B Tartaglione F Federico, et al. 2009 Rate of MMSE score change in Alzheimer's disease: influence of education and vascular risk factors Clin Neurol Neurosurg 111 327 330 19036496 10.1016/j.clineuro.2008.10.006
31. C Sanz S Andrieu A Sinclair, et al. 2009 Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease Neurology 73 1359 1366 19858457 10.1212/WNL.0b013e3181bd80e9 1:STN:280:DC%2BD1MjhvFCrsw%3D%3D
32. I Skoog B Lernfelt S Landahl, et al. 1996 A 15-year longitudinal study of blood pressure and dementia Lancet 347 1141 1145 8609748 10.1016/S0140-6736(96) 90608-X 1:STN:280:DyaK287pvVersQ%3D%3D (Pubitemid 126512042)
33. I Skoog H Lithell L Hansson, et al. 2005 Effect of baseline cognitive function and antihypertensive treatment on cognitive and cardiovascular outcomes: study on cognition and prognosis in the elderly (SCOPE) Am J Hypertens 18 1052 1059 16109319 10.1016/j.amjhyper.2005.02.013 1:CAS:528: DC%2BD2MXos1aisbs%3D (Pubitemid 41139903)
34. Talairach J, Tournoux P (1998) Co-planar stereotactic atlas of the human brain. New York, Thieme
35. The Japan Atherosclerotic Society (2007) Guidelines for prevention of atherosclerotic cardiovascular diseases. Kyowakikaku, Tokyo
36. The Japan Diabetic Society (2010) Treatment Guide for Diabetes. Bunkodo, Tokyo
37. The Japanese Society of Hypertension (2009) Guidelines for the management of hypertension. Life Science, Tokyo
38. GA van Kan Y Rolland F Nourhashemi, et al. 2009 Cardiovascular disease risk factors and progression of Alzheimer's disease Dement Geriatr Cogn Disord 27 240 246 10.1159/000203365
39. T Yoshitake Y Kiyohara I Kato, et al. 1995 Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: the Hisayama study Neurology 45 1161 1168 7783883 1:STN:280:DyaK2Mzgtlarsw%3D%3D